Michael H. Tirgan, MD

KRF was established in 2011 by Dr. Michael H. Tirgan. Dr. Tirgan is board certified internist and medical oncologist (cancer specialist) with special interest in keloid disorder. Over past several years, Dr. Tirgan's medical practice has been focused on treatment of patients with keloid disorder. Dr. Tirgan is on staff at Mount Sinai St. Luke's / Roosevelt Hospital Center as well as the Rockefeller University Hospital in New York City.

Patricia L. Danielsen, MD, PhD

Dr. Patricia L. Danielsen is a dermatologist at the Department of Dermatology and Copenhagen Wound Healing Center, Copenhagen University Hospital, Denmark. She has a PhD in wound healing and scar treatment science and a continuing academic career with a special focus on keloid scar disease. Dr. Danielsen has had clinical training in Denmark, Switzerland, Germany and the UK as well as scar tissue research in Denmark and Australia. She is a board member of the European Tissue Repair Society. Dr. Danielsen is member of Board of Directors of Keloid Research Foundation.

Reza Ghohestani, MD, PhD

Dr. Reza Ghohestani is an academic dermatologist, and a basic science researcher, based in in San Antonio, Texas. For years, Dr. Ghohestani has lent his support to KRF. He has been the force behind our Spring 2017 Symposium in Marrakesh and also the visionary for establishing the Journal of Keloid Research. KRF is happy to have Dr. Ghohestani as a member of its Board of Directors.

Tae Hwan Park, MD, PhD

Dr. Tae Hwan Park is a board certified plastic surgeon in the Department of Plastic and Reconstructive Surgery and assistant professor at CHA Bundang Medical center in South Korea. He is author of numerous keloid publications. Dr. Park has extensive experience in treating patients with keloid disorder. KRF is happy to have Dr. Park as a member of its Scientific Board.


    2nd International Keloid Symposium:

    (Januar 18, 2018) KRF is proudly announcing that the 2nd will be held on June 7-8, 2018 in Rome, Italy. Click on the image below to be directed to the symposium website.

    Notice of 501 (C)(3) Status:

    (February 1, 2017) Keloid Research Foundation has been determined by the US Internal Revenue Service (IRS) to be exempt from federal income tax under Internal Revenue Code (IRC) Section 501(C)(3). Donors can deduct contributions they make to KRF under IRC Section 170. Click here to view the 501(C)(3) Exemption Document.

    Journal of Keloid Research:

    (December 3, 2016)KRF is proud to announce establishment of Keloid Research, an open access scientific publication of the Keloid Research Foundation. Until now, keloid manuscripts have been published in a variety of journals. Our goal is to create a centralized publishing platform for all researchers who are passionate about this disorder, so that relevant clinical and laboratory research can be published in one place and under one umbrella. The journal is aiming to provide an international forum for the publication of original work, describing basic science, translational and clinical investigations in keloid disorder.

    Keloid Staging System:

    (August 19, 2016) In his most recent publication, "Neck Keloids: evaluation of risk factors and recommendation for keloid staging system" Dr. Tirgan has designed a staging system that allows for proper categorization and grouping of keloid patients into various stages.

    To assess each keloid patient properly, to better understand the natural history of this disorder, and to be able to compare future keloid study results among various patients groups, we clearly need a staging system that can allow us to describe the severity keloid disorder based on the size, location and/or extent of the keloidal lesions; as well as history of surgery or radiation therapy, and perhaps other factors that are currently unknown to us. Please click HERE to read more.